SPEECH BY THE PRESIDENT OF THE REPUBLIC ON THE OCCASION OF THE INSTALLATION CEREMONY OF THE ACADEMY OF THE WORLD HEALTH ORGANIZATION IN LYON

France Emmanuel Macron · President of France

27 September 2021 · Installation ceremony of the Academy of the World Health Organization · Lyon, France

Context
Macron addressed the installation ceremony of the WHO Academy in Lyon on September 27, 2021, celebrating its establishment and outlining France's global health priorities.
Main themes
WHO Academy in Lyon, global health training, pandemic lessons learned, public-private partnership, health solidarity, French global health strategy, multilateral cooperation, health workforce capacity building
Duration
~36 min
88th percentile
Words
4,344
88th percentile
Sentences
188
88th percentile
Readability
45
48th percentile
Grade
12.7
53rd percentile
Syntax
3.10
60th percentile
Vocabulary
2.11
30th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 32%31%
  • Ceremonial 24%23%
  • Economic 22%22%
  • Geopolitical 9%9%
  • Institutional 8%7%
  • Technological 3%3%
  • Environmental 3%3%
  • Not in focus 2%

188 sentences in 38 paragraphs

Mr. Director-General of the WHO, dear Dr. Tedros,

Madam Secretary General of the International Organization of La Francophonie, dear Louise,

Madam Secretary General of the Commonwealth,

Ladies and gentlemen Ministers, Mr. Mayor,

Mr. President of the Regional Council,

Mr. President of the Metropolis,

Ladies and gentlemen French and European parliamentarians, ladies and gentlemen elected officials,

Mr. Regional Prefect,

Ladies and gentlemen ambassadors,

Madam Director of the Academy,

Ladies and gentlemen, dear friends,

I feel that you are beginning to have a clear idea of this academy and being aware that I am the last to speak, I will also try to thank those who deserve it, but also to say a few words about the Academy and the importance it holds for us collectively, to say a few words about the pandemic we are currently experiencing and what it has taught us. This academy will also contribute to elements of solidarity and finally, a few words about our global health strategy in support of that of the WHO, of course, and as a member.

Mr. Director-General, you have all unveiled the conditions that presided over both the announcement, the decision, and today, this installation ceremony. So, there was the idea, our first discussion, and it is my duty to thank you and to thank, along with you, all the teams of the World Health Organization, to also thank all the French diplomatic teams. You had the kindness to mention our ambassadors, and I want to thank them here, who, at the WHO in their health mission or at the permanent representation in Geneva, played a decisive role. I also want to thank Professor Agnès BUZYN who then accepted to take up the torch and explained to us earlier the work that has been hers and the perspectives that are now ours. So, thank you for that to you, your teams, and all the diplomatic teams present here. I will then thank the elected officials because this would not have been possible without the city, the metropolis, and the regional council taking up this subject with the commitment we saw earlier. Georges KÉPÉNÉKIAN has been mentioned several times, but that is normal, he was then mayor, he was also a doctor, and we know his commitment to these issues. I really want to thank Georges for believing in it, for carrying it, and for allowing, with his successor, with the president of the metropolis and the president of the regional council, to have formed this team and decided to invest. And Mr. President of the Regional Council, you indeed indicated the commitment of your regional council, the choice that has been made and which is very strong, and I thank you for that because it is what has allowed us to have, if I may say, a concrete object behind what was an idea that continued to prosper. I also want to thank the regional prefect, Pascal MAILHOS, who worked to ensure that all stakeholders could move forward and who, in connection with the three ministers present here and their teams, thank you immensely for all this work, with local elected officials, made all this possible.

Then, when we talk about Lyon, we talk about a unique spirit of cooperation between the public and private sectors - which, for too long in France, has been opposed - are, for a long time, united in Lyon. And this has been mentioned, but Lyon entrepreneurs believed in it early on. And in particular, I really want to thank Alain MÉRIEUX for his commitment, his work. He is part of an illustrious lineage, but he has, on several occasions in our history, shown that he knows how to see far when it was necessary to develop new international partnerships, he was there. When it was necessary to advance on many issues, he was there. And with the entire company, his son, they have been able to mobilize their company, the patrons, very strongly. And so, I want to thank all the patrons who are committing: Sanofi, dear Serge who is very strongly committed, thank you very much, the Mérieux Institute, Boehringer, Total, the National Company of the Rhône, JCDecaux, and Olivier GINON, April who confirmed it to me earlier, who will therefore engage alongside the local authorities. I know that several companies present here are seriously considering it. And I very much hope that they will be alongside this academy project to enable us to go further. I want to thank Gérard MESTRALLET, who also worked with the minister to mobilize the entire national private ecosystem and who will continue in the coming weeks and months, based on this event, to work in this direction.

This academy, as has been said, will play an extremely important role within the framework of the WHO strategy, I will not go back over the figures that have been given, but it will also play an important role for us, that is to say, for the strategy we want to pursue in terms of research, health policy, and solidarity in this area. Several have mentioned it before me, this academy will therefore train not only caregivers but also health executives, a whole ecosystem. And it is an extremely important relay of the strategy in which we believe and that we are deploying at the national level. The one that led to the establishment of the Ségur de la santé with an unprecedented investment of more than 8 billion euros per year. The one that led to the establishment of a programming law for research, with the organizations present here. Universities have also established a strategy of more than 25 billion euros in additional funding strategies. And what we announced a few months ago - a Health Innovation Strategy 2030 that will, in the coming years, invest 7.5 billion euros in innovation and breakthrough innovation in health - this academy fully fits into this strategy.

And indeed, it is important that the city, the metropolis, the region, and the whole of France can deploy all the synergies that will allow us to go further thanks to this. First, by developing around the Lyon hub, which already has this strength, and the Academy, several centers of excellence - this has been mentioned and I fully subscribe to it - in the field of, against infectious diseases and in terms of breakthrough innovation on these issues. And so the university, the research organizations present here, the actors from the private sectors who have also decided to reinvest in the region - I was among you a few months ago, to innovate precisely certain centers of excellence and relocation - will make even more of your hub, a mall of innovation and production, on the one hand, in the fight against infectious diseases, on the other hand, in monitoring, but also in the relocation of our pharmaceutical production. And the idea is also to make the region a hub developing all the synergies with other sectors that will allow us to have development and production on the breakthrough innovations on which France has sometimes lagged behind, particularly for vaccines, particularly for Messenger RNA.

Next, and this is the second element I wanted to emphasize that fits into this national and European strategy around the Academy, we will be able to truly create a mall of training for all health professionals. There is obviously everything that will be done within the framework and with the World Health Organization, there is what we want to do for ourselves, both public and private sectors, to train in initial training throughout the careers of our health professionals, our health executives, and our medico-social professions. We have immense needs today. We have training needs in these areas and requalification of these professions, which is also at the heart of the Ségur strategy and the requalification of many medico-social jobs. And we also need to develop training hubs, initial training and lifelong training.

Around this academy, there is a unique opportunity to also develop training, not just for the region, but for the whole of France, and to have one of these centers of excellence that will allow us to provide these health professionals with training that will fit into national training linked, by the way, with our universities, but also in international training that the WHO allows access to.

And finally, we will be able to make the site France, if I may say, a place of health training in the world of Francophonie, dear Louise. And I think this is an absolutely extraordinary lever for what we want to do, and thank you for your commitment, to further develop Francophonie. As part of the partnership we want to rebuild with the African continent, the idea of having here a training hub, physical but also digital, will be a tremendous relay for what our universities and research organizations have also begun to do, to help train throughout the African continent, health professionals and health executives. This is essential and I will return to it in a moment if we want to succeed in a true strategy of solidarity in terms of health internationally. And so we will be able to develop here what is a strategy for Francophonie, but also a strategy for French training.

You understood it, it was indeed a crazy dream. Collectively, you are enabling it to come true. But it is a concrete achievement that, beyond what it brings and contributes to the project of the World Health Organization, will allow us to multiply France's efforts in this area, but also in terms of research, in terms of training, and in terms of training internationally and towards the African continent, will allow us to go much further and much stronger.

The third element I wanted to return to is precisely our strategy of solidarity in health in the context of the pandemic. And this academy fully fits into this objective. Indeed, for the past 18 months, we have all fought hard against this virus that comes after many others and which, if I may say, is almost the daily reality for the World Health Organization and for several of you who are fighting for vaccination around the world or for care around the world. But it is true that since the spring of 2020, our fellow citizens have lived in their flesh and in their lives the consequences of this epidemic that continues to strike even more cruelly than ours, many other continents.

I will not go back here on what Dr. Tedros said about what we have done, but I want to share with you some additional convictions about what we have done and which is, in my eyes, absolutely essential for us to learn from the crisis. First, we do not emerge from a crisis and a global pandemic without solidarity. This crisis has been a tremendous lever of innovation. Humanity has never developed a vaccine for humans in less than a year, never. It has been a tremendous lever for many companies, for the creation of wealth, values, and jobs as well. And it has been a challenge for all of us in organizing vaccination campaigns, and we are succeeding in it.

This is a tremendous achievement. But we would be shortsighted or unaware to consider that the battle is thus won. What this crisis also teaches us is that we do not emerge from a global pandemic without a global strategy. And this is what the WHO has been advocating for several months in terms of vaccination, and it is what we must not forget at the moment we are speaking. France has indeed been one of the member states that has pushed hard for the creation of ACT Accelerator, as the Director-General recalled. This is what has allowed us to deploy a strategy of diagnostics, care, but also of vaccination deployment with the Covax initiative. I thank our European deputy for having accepted to take on responsibilities within ACT-A and to move forward.

France announced a few days ago that we would double our vaccine donation: 120 million doses will be given, which is more than what we have deployed on our soil today. And this in the short term, not in the years to come, because the battle is now.

But what we have learned is that this strategy needs a few simple elements to be completed. First, we must be clear; it cannot simply be about donating doses. It must be about donating doses in the short term, but on the one hand, there needs to be more transparency, and this is where the World Health Organization has a key role. ACT-A plays an essential role, and I want to thank Gavi, the Global Fund, UNICEF, Unitaid - dear Marisol - and the Wellcome Trust, who, under the auspices of the WHO, are making progress with partners. But we need to bring much more transparency to these issues. Otherwise, we are exchanging billions, absolutely staggering numbers of doses, and when we compare that to what is happening on the ground, it is incomprehensible for the citizens of those countries. Transparency, accountability, and monitoring. Under the auspices of the WHO, we advocate for going much further in this area.

This is absolutely essential, and that is why France, at the next G20, will advocate for a truly binding code of conduct to be put on the table to support the action of the WHO, a code of conduct that incorporates key principles with one objective: the effectiveness of health security and a compass, equity, but which must clearly state the transparency regarding purchasing conditions in the case of pre-orders, regarding volumes, regarding delivery conditions, regarding pricing conditions. Because today, my conviction is that we make many promises, but the billions we put on the table are sometimes very late. No one knows how much the doses are purchased from pharmaceutical laboratories. And so I think that today there is profit being made in the name of solidarity, and that is not the values we uphold. A discourse of truth is necessary, under international supervision, reinforcing the role of the WHO, but with member states committing to a clear code of conduct. This is essential.

The second thing, if we want to move forward, is obviously to complement this with what the Italian presidency is proposing within the G20: a political discussion that needs to be held. I will return to this.

Next, alongside transparency, there is the transfer of technology. I invite all the pharmaceutical companies present here, who I know are already doing a lot and have historically been present on the African continent through their companies or foundations, to help us do even more in terms of technology transfer.

When there is a crisis, selfishness resurfaces. And when vaccines are not made on-site, they arrive late on-site, let’s be clear. Despite all the goodwill in the world. I want to celebrate Europe here in this city, this region so European. Europe, we do not say it enough, is the only place in the world where we have exported 50% of the vaccines we have produced. There is no other place where this has been the case. Our American friends have imposed export bans everywhere and sometimes blocked production elsewhere. They have given doses since this summer; they did not export any doses during the peak of the crisis. At the very moment we were fighting to accelerate at home, we had already exported half of the doses produced. In February, in March, it was already the case. Neither the United States, nor China, nor the countries of the Near and Middle East, nowhere else has there been such an openly assumed policy. I think we can and we must be proud of that. There were no export restrictions. There has never been a blockage.

But alongside that, we must develop vaccine production in middle-income countries, particularly in African countries. Today, Africa has vaccinated 3 to 4% of its population. The difficulty is that vaccines took time to be delivered because they were produced where we need them more. At one point in India, which was blocked on its production by export bans, and which then had to face its own crisis. Africa accounts for 20% of global vaccine needs, but only 1% of production. There is no inevitability to this. We must commit massively to developing more companies, not just assembly, fill and finish, but truly production on the African continent. Several countries are candidates. We wish to develop this strategy with the WHO. It is absolutely essential. And it is good for us. It is this cooperation that is win-win and that is fairer. The transfer of technology is absolutely indispensable.

The third element regarding the solidarity policy that COVID has taught us is that we indeed need, and this is the link with this academy, to train and continue to support primary health systems. The President of the Regional Council recalled the intuitions of your father, dear Alain, and the clear message of what all those deploying vaccination strategies see on the ground. It is false to think that one can give vaccines to a country, and it will manage on its own and deploy a vaccination strategy. What we are seeing today in Africa are countries that have received doses and are unable to deploy their vaccination strategy as they should. So we have tremendous levers, UNICEF is part of that, and does extraordinary work in this area. And thanks, by the way, to what the Global Fund has deployed with all stakeholders and UNICEF, we know that we can deploy vaccination campaigns with international organizations. I mention this because it was here, in the fall of 2019, with several of you, that we engaged France to do more with the famous Global Fund. But we need to train health professionals in all countries. We need to strengthen primary care systems in all countries, and we must not think that health problems will disappear with COVID-19. That is false; on the contrary. And so the policy of training and strengthening health systems and the Academy will play a key role, but our development aid policies must go more in this direction. It is essential. Let us not lose sight of the fact that billions or doses of vaccines should somehow be taken as a final settlement. That would be a disastrous mistake. It is indeed in this strategy that we have engaged the French Development Agency, but we wish to do more thanks to and through the Academy.

Finally, a few words on our global health strategy. Many things have been said here by my predecessors, but beyond the fight against the pandemic and the messages I have just conveyed. This Academy, as it is at the intersection of health, training, and humanity, was indeed an intuition that—we all see it—can only be reinforced by the crisis. But we are all facing a real change in international strategy, and France will contribute to it. First, we can no longer think and organize health and health policies as something that can be isolated from the rest. The One Health strategy, which we launched together on the sidelines of the Paris Peace Forum through this international initiative, is the one that establishes the coherence of an approach through human health, animal health, and the fight against climate change and for biodiversity. It is the conviction, in a way, that ecosystems are a whole that sustains life through both these synergies and these interdependencies. And our activities, which will continue to be carried out, will continue to develop through innovations and development policies.

Will be integrated at their core the consequences that until now we only considered as external to the model. And so, the One Health strategy is a true revolution in the conception and development of our production models, but also in the organization of international cooperation, which consists of saying that the fight against epidemics, the zones as well, the balances of ecosystems are interconnected, and are one and the same fight. That is why we have begun to launch the first research programs at the French and European levels in this area, and that, alongside the Director-General of the WHO, we are in favor of this One Health policy that aims to resynchronize all our agendas. We cannot have other strategies than those that integrate these profound revolutions in our modes of production, but which is also a tremendous source of innovation, research, and creation of added value and jobs if we know how to draw all the consequences from it.

Our global strategy, then, will rely on more innovation. Everything I have just told you has a consequence. The public sector as well as the private sector, in developed countries as well as in middle-income or poor countries, will need to invest more in their research, education, and innovation strategies in health. This is a certainty. The equations we lived with until now are no longer realistic equations. First, because there is an acceleration of developments and the consequences we have to face. We will have repetitions of crises that will be global. And then because Europe must reinsert itself into international competition. And it is enough to look at the amounts we need to invest in terms of research, innovation, and economic development and to look at our Chinese and American competitors. That is why we have begun to reinvest several billion euros in research, innovation, particularly in health, as I mentioned a moment ago, and that is why, as Europeans, particularly through the ERA agency and the strategy we want to deploy with the Commission, we must invest much more. In disruptive innovation, in major changes, but we must assume these choices.

The third element, all of this requires rethinking international cooperation in terms of financing and health. This is the proposal made by the Italian presidency of the G20, based on the Monti report, to have a more political council bringing together health and finance expertise, to coordinate the decisions of G20 governments and to assume this change of scale and especially to rethink international cooperation in this area. I am in favor of this because we must, in terms of public finances, think about the consequences, convince financial markets that our private and public actors must change scale in this area, and build cooperation strategies among major powers in this area. Cooperation strategies that will allow the poorest and middle-income countries to participate in this transformation. But we must also create, as Europeans, the strategy of sovereignty and independence that will allow us to achieve this. And it is simple; if we do not have the right level of investment in research, development, and innovation, in artificial intelligence, personalized medicine, preventive and predictive medicine—and the synergies are known to the actors I am speaking to here today, recognizing many faces in this regard—but also in all the innovations we have seen beginning to deploy in recent years. If we do not invest massively, public and private sectors, innovations will happen elsewhere with the consequences we have known in times of crisis, but above all, the technological choices and choices in terms of public health, the model behind it, the model of data protection, the model of individual risk protection, the models of risk management—where we have always protected a socialization of risk, a respect for private life—will be made in other continents than ours. If innovation is Chinese or American, innovation will be determined by a government thousands of kilometers away that does not share the same values as us or by a private sector thousands of kilometers away that also does not share the same convictions and values as us, neither in terms of solidarity nor in terms of protection of individual data. This is a fact. It is therefore also a political duty for Europe to contribute to this work and to be at the heart of this new international strategy.

Here are the few words I wanted to share with you to say that this strategy, of course, the World Health Organization will play an essential role. And I want to say here, Mr. Director-General, that France will always stand by your side. Not just personally, but institutionally. Our duty in the coming period is, on the one hand, to strengthen our early warning mechanisms. This is one of the responsibilities of the World Health Organization. We must act faster, clearer, and stronger in times of crisis. This requires being uncompromising on the responsibility of each member state regarding its responsibilities in terms of alert. No member state of the World Health Organization should be able to conceal information or delay the transmission of that information. This is a duty within the Community of Member States in this regard. Third point: we must protect the World Health Organization from any form of political interference. We are talking about science, not politics. And fourth, we must defend with all our strength within the World Health Organization the protection of free and open science. These are the values that France believes in, these are the values that have presided over health and scientific multilateralism, these are the values that we must not allow to be corrupted by anyone. In this regard, France will play its role because it is its history, because it is its vocation.

There you go, my dear friends, the few words I wanted to exchange with you today, but above all to express my immense pride in being by your side for this installation ceremony. I thank each and every one of you for the work, the commitment, the conviction that is yours, and I want to say that we will be proud to continue pursuing this project because it is at the heart of everything we believe in. Thank you very much.

Long live the WHO, long live the Republic, and long live France!